Tokushima Anti-Oxidation Clinical Trial In hypertensives, Cilnidipine versus Amlodipine
Not Applicable
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000001719
- Lead Sponsor
- Cardiovascular Medicine, The University of Tokushima Institute of Health Biosciences, Graduate School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1.Malignant hypertension 2.Pregnant women,or Women suspected of being pregnant. 3.Severe liver disorder. 4.Patients who are inadequate to enter this study due to the other reasons by physician's judgments.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Clinic blood pressure,heart rate. 2.Home blood pressure,heart rate. 3.urinary 8-OHdG. 4.hs-CRP 5.urinary albumin-creatinine ratio. 6.urinary L-FABP. 7.LDL-C,TG,HDL-C,BUN,Cr,*HbA1c*fasting blood glucose(*Patients with diabetes)
- Secondary Outcome Measures
Name Time Method